Tectonic Therapeutic, Inc. Cash Flow Statement

Cash Flow Statement Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -44.57M-72.97M-119.71M-119.13M-105.89M-44.60M-53.86M
Share-based Compensation 0.18M2.20M6.80M15.63M18.58M11.52M1.12M3.49M
Deferred Taxes 0.38M
Gains from Investment Securities 0.02M0.41M3.51M2.08M1.83M-0.06M0.50M-0.54M
Asset Writedowns and Impairment 0.23M1.88M
Cash from Operations -16.38M-37.65M-67.67M-98.80M-98.03M-97.21M-40.68M-59.08M
Depreciation, Depletion & Amortization
Amortization of Deferred Charges 0.02M0.04M
Depreciation & Amortization (CF) 0.04M0.38M0.85M1.21M1.40M1.44M1.48M1.65M
Change in Working Capital
Change in Account Payables 0.18M2.02M1.03M-0.88M0.80M-3.10M-0.17M-1.42M
Change in Accured Expenses 1.45M5.31M1.92M3.94M2.15M-3.91M1.61M-5.64M
Other Working Capital Changes 0.50M3.04M4.89M-1.10M2.02M-2.47M1.02M3.19M
Investing Activities
Capital Expenditures 0.38M1.83M1.58M1.18M2.46M0.27M0.28M0.16M
Sales of Property, Plant and Equipment 83.74M
Cash from Investing Activities -0.38M-1.83M-1.58M-1.18M-2.46M-0.27M-0.28M-0.16M
Financing Activities
Other financing activities 0.04M0.10M
Cash from Financing Activities 17.37M160.29M129.99M172.62M30.37M0.26M33.75M171.71M
Additional items
Exchange Rate Effect 0.02M-0.01M
Change in Cash 0.61M120.81M60.74M72.64M-70.11M-97.21M-7.20M112.47M
Free Cash Flow -16.77M-39.48M-69.25M-99.98M-100.49M-97.47M-40.96M-59.24M
Net Cash Flow 0.61M120.81M60.74M72.64M-70.11M-97.21M-7.21M112.48M